Lecanemab in Early Alzheimer’s Disease
Lecanemab reduced markers of amyloid in early Alzheimer's disease and resulted in moderately less decline on measures of cognition and function than placebo at 18 months but was...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 4,288
- Institution
- National University of Singapore
External Links
Identifiers
- ORCID
- 0000-0002-1047-9225
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.